Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02068040 · ClinicalTrials.gov registry record · NA
Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF)
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02068040: Completed NA study, sponsored by University of California, San Diego.
NCT02068040 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02068040, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The major goal of this proposal is to characterize the ability of epicatechin which a component of dark chocolate to improve the 1. structural and functional features of skeletal muscle (SkM) 2. exercise capacity (as assessed by VO2 max) 3. parameters of diastolic heart function (as assessed by echocardiography) We propose that a 3 month treatment with epicatechin (through CocoaVia® capsules) will lead to a significant improvement in exercise capacity and diastolic function.
Primary Outcome
Objectively evaluate exercise capacity through cycle ergometry to measure VO2 max
Interventions
- DIETARY_SUPPLEMENT CocoaVia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT02068040 record still lists
NCT02068040 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which CocoaVia is the first listed.
NCT02068040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02068040 about?
NCT02068040 is a clinical study titled "Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF)". The major goal of this proposal is to characterize the ability of epicatechin which a component of dark chocolate to improve the 1. structural and functional features of skeletal muscle (SkM) 2. exercise capacity (as assessed by VO2 max) 3. parameters of diastolic heart function (as assessed by ech...
What is the current status of trial NCT02068040?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2014-01. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02068040?
The interventions under investigation include: CocoaVia (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02068040?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02068040's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia